Safety and efficacy study of MRE0094 to treat chronic, neuropathic, diabetic foot ulcers.

Trial Profile

Safety and efficacy study of MRE0094 to treat chronic, neuropathic, diabetic foot ulcers.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2012

At a glance

  • Drugs Sonedenoson (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors King Pharmaceuticals Research and Development
  • Most Recent Events

    • 30 Jan 2008 Actual patient number 322 added as reported by ClinicalTrials.gov.
    • 30 Jan 2008 Status change from in progress to completed.
    • 29 Aug 2007 Status change from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top